Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
971.00
835.00
752.00
554.00
555.00
611.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
84.00
52.00
43.00
32.00
35.00
48.00
Net Sales
886.00
782.00
709.00
522.00
519.00
563.00
Expenditure (Ex Depriciation)
Stock Adjustments
-23.00
-64.00
-1.00
36.00
-112.00
26.00
Raw Materials Consumed
516.00
496.00
425.00
299.00
387.00
313.00
Power & Fuel Cost
62.00
56.00
47.00
35.00
32.00
23.00
Employee Cost
87.00
80.00
64.00
53.00
51.00
41.00
Operating Expenses
28.00
29.00
26.00
17.00
22.00
16.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
13.00
19.00
4.00
3.00
3.00
5.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
3.00
2.00
2.00
2.00
2.00
2.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
715.00
643.00
592.00
467.00
405.00
442.00
Operating Profit (PBDIT) excl Other Income
171.00
138.00
116.00
54.00
114.00
121.00
Other Income
8.00
6.00
4.00
4.00
5.00
3.00
Operating Profit (PBDIT)
179.00
145.00
121.00
59.00
119.00
124.00
Interest
23.00
18.00
23.00
21.00
18.00
11.00
Profit before Depriciation and Tax
156.00
126.00
97.00
37.00
100.00
113.00
Depreciation
39.00
34.00
31.00
32.00
32.00
22.00
Profit Before Taxation & Exceptional Items
116.00
92.00
66.00
5.00
68.00
91.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
116.00
92.00
66.00
5.00
68.00
91.00
Provision for Tax
28.00
24.00
16.00
1.00
0.00
30.00
Profit After Tax
87.00
67.00
49.00
3.00
67.00
60.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
380.00
324.00
287.00
297.00
247.00
195.00
Profit Available for appropriations
482.00
394.00
337.00
290.00
309.00
257.00
Appropriations
482.00
394.00
337.00
290.00
309.00
257.00
Equity Dividend (%)
40.00%
40.00%
40.00%
30.00%
30.00%
30.00%
Earnings Per Share
9.58
8.16
5.89
-0.83
7.35
7.39
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 13.30% vs 10.36% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 23.23% vs 19.18% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 24.46% vs -20.96% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 30.56% vs 36.99% in Mar 2025
Compare Profit and Loss Results of SMS Pharma.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
971.00
292.00
679.00
232.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
84.00
0.00
84.00
0%
Net Sales
886.00
292.00
594.00
203.42%
Expenditure (Ex Depriciation)
Stock Adjustments
-23.00
-41.00
18.00
43.90%
Raw Materials Consumed
516.00
178.00
338.00
189.89%
Power & Fuel Cost
62.00
0.00
62.00
0%
Employee Cost
87.00
86.00
1.00
1.16%
Operating Expenses
28.00
5.00
23.00
460.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
13.00
19.00
-6.00
-31.58%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
715.00
298.00
417.00
139.93%
Operating Profit (PBDIT) excl Other Income
171.00
-5.00
176.00
3,520.00%
Other Income
8.00
2.00
6.00
300.00%
Operating Profit (PBDIT)
179.00
-3.00
182.00
6,066.67%
Interest
23.00
10.00
13.00
130.00%
Profit before Depriciation and Tax
156.00
-14.00
170.00
1,214.29%
Depreciation
39.00
43.00
-4.00
-9.30%
Profit Before Taxation & Exceptional Items
116.00
-57.00
173.00
303.51%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
116.00
-57.00
173.00
303.51%
Provision for Tax
28.00
0.00
28.00
0%
Profit After Tax
87.00
-56.00
143.00
255.36%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
380.00
-1.00
381.00
38,100.00%
Profit Available for appropriations
482.00
-58.00
540.00
931.03%
Appropriations
482.00
-58.00
540.00
931.03%
Equity Dividend (%)
40%
10%
30.00
Earnings Per Share
9.58
-20.68
30.26
146.32%
Profit And Loss - Net Sales
Net Sales 886.87 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.30% vs 10.36% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 171.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 23.23% vs 19.18% in Mar 2025
Profit And Loss - Interest
Interest 23.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 24.46% vs -20.96% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 88.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 30.56% vs 36.99% in Mar 2025